Program highlights
Now available for testing and feedback
Download and test the Access Barrier Cause-Effect Canvas.
Now available for testing and feedback
Participate now in a public consultation for the co-created Country and Condition Cards for Precision Medicine.
DNA tests for tumours can be a game-changer
Patient story: A cutting-edge DNA test put Inke Logtenberg on the right treatment path. Now she hopes others with Cancer of Unknown Primary (CUP) will have swift access to personalized care
(2/3) We were successful, but the mystery is not yet history. We must continue to raise alarm bells on enhancing ... access to better molecular diagnostics/personalised diagnostics/CGP & targeted treatment/trials for all cancer patients.
https://www.worldcupawareness.org/
#MakeTheMysteryHistory
Oncology is leading the way in #precisionmedicine, as the genomic and other molecular characteristics of patients ... and their tumors are routinely collected at scale.
Discover how Project GENIE initiated by @AACR will help improve clinical-decision making.
https://bit.ly/3ClwEFD
🗓️ Still time to register for the 2nd edition of the @KRASKickers Connect on Sept 30 - Oct 1. Attend the event... in person or connect online to learn about the latest in research, clinical trials, and survivorship from experts & advocates in the #KRAS community
#biomarkers
About us
Our motivation
All patients deserve access to the right testing & treatment at the right time. While Precision Medicine (PM) can transform lives, its potential benefits have not yet been fully realized.
Our ambition
Our goal is to improve access to precision medicine for all patients who could benefit from it, by generating better evidence, creating awareness and building the conditions for better access, starting with testing and cancer.
The partnership
We are an independent, nonprofit, global and multistakeholder consortium, building solutions with patients, for patients. Its members and community include individual patients, patient organizations, pharmaceutical & diagnostics companies, healthcare professionals and medical societies, payers, HTA bodies and regulators.
Keep up to date with developments from the precision medicine ecosystem
We don’t spam. Just key info at the right time.
Members
